2016
DOI: 10.1002/nbm.3568
|View full text |Cite
|
Sign up to set email alerts
|

Effects of fasting on serial measurements of hyperpolarized [1‐ 13 C]pyruvate metabolism in tumors

Abstract: Imaging of the metabolism of hyperpolarized [1‐13C]pyruvate has shown considerable promise in preclinical studies in oncology, particularly for the assessment of early treatment response. The repeatability of measurements of 13C label exchange between pyruvate and lactate was determined in a murine lymphoma model in fasted and non‐fasted animals. The fasted state showed lower intra‐individual variability, although the [1‐13C]lactate/[1‐13C]pyruvate signal ratio was significantly greater in fasted than in non‐f… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
17
0

Year Published

2017
2017
2018
2018

Publication Types

Select...
6

Relationship

5
1

Authors

Journals

citations
Cited by 18 publications
(17 citation statements)
references
References 30 publications
0
17
0
Order By: Relevance
“…Tumors were established by subcutaneous inoculation of a suspension of 5 × 10 6 viable EL4 murine lymphoma cells (in a volume of 100 μL) in the left flank of C57BL/6 mice (Charles River Ltd., Harlow, Essex, UK) ( n = 69) at 6–8 weeks of age, when the animals were ~20 g. Studies were performed when the tumors had grown to a size of ~2 cm 3 , which was typically 10 days following implantation. Animals, which were not submitted to any dietary restriction, were anesthetized by either inhalation of 1–2% isoflurane (Isoflo, Abbotts Laboratories Ltd., Maidenhead, Berkshire, UK) in air/O 2 (75%/25%, 2 L/min) or by intraperitoneal administration of 10 mL/kg body weight of a 5: 4: 31 mixture of Hypnorm (VetaPharma, Sherburn‐in‐Elmet, Leeds, North Yorkshire, UK), Hypnovel (Roche, Welwyn Garden City, Hertfordshire, UK) and saline ( n = 5). Body temperature was maintained by blowing warm air through the magnet bore.…”
Section: Methodsmentioning
confidence: 99%
“…Tumors were established by subcutaneous inoculation of a suspension of 5 × 10 6 viable EL4 murine lymphoma cells (in a volume of 100 μL) in the left flank of C57BL/6 mice (Charles River Ltd., Harlow, Essex, UK) ( n = 69) at 6–8 weeks of age, when the animals were ~20 g. Studies were performed when the tumors had grown to a size of ~2 cm 3 , which was typically 10 days following implantation. Animals, which were not submitted to any dietary restriction, were anesthetized by either inhalation of 1–2% isoflurane (Isoflo, Abbotts Laboratories Ltd., Maidenhead, Berkshire, UK) in air/O 2 (75%/25%, 2 L/min) or by intraperitoneal administration of 10 mL/kg body weight of a 5: 4: 31 mixture of Hypnorm (VetaPharma, Sherburn‐in‐Elmet, Leeds, North Yorkshire, UK), Hypnovel (Roche, Welwyn Garden City, Hertfordshire, UK) and saline ( n = 5). Body temperature was maintained by blowing warm air through the magnet bore.…”
Section: Methodsmentioning
confidence: 99%
“…Tumors were obtained by subcutaneous implantation of EL4 murine lymphoma cells, as described in Reference . Mice were fasted for 6–8 h before imaging . Images were acquired at 7 T and the [1‐ 13 C] pyruvate was hyperpolarized as described previously .…”
Section: Methodsmentioning
confidence: 99%
“…A reference FSE proton image was acquired as a single axial slice (6‐10 mm thick) that encompassed both feet including the heel, up to where the top of the talus meets the leg. [1‐ 13 C]pyruvate (99% 13 C labelled, 44 mg) in a solution containing 15 mmol/l of trityl radical, tris(8‐carboxy‐2,2,6,6‐tetra(hydroxyethyl)‐benzo‐(1‐5)‐bis‐(1,3)‐dithiole‐4‐yl)‐methyl sodium salt (OX063; GE Healthcare, Amersham, UK) and 1.5 mmol/l gadolinium chelate (Dotarem, Guerbet, Paris, France) was polarized as described previously43 using a Hypersense dynamic nuclear polarization (DNP) system (Oxford BioTools, Abingdon, UK). The sample was dissolved in superheated (180°C, ~10 bar) buffer (40 mM 4‐(2‐hydroxyethyl)‐1‐piperazine‐ethanesulfonic acid (HEPES), 94 mM NaOH, 30 mM NaCl and 50 mg/l ethylenediaminetetraacetic acid (EDTA)) to give a final pyruvate concentration of 0.82 M, 200 μl of which was injected via a tail vein.…”
Section: Methodsmentioning
confidence: 99%